RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets

New NK cell platform extends RMTG's cellular-technology portfolio into immunology-adjacent applications, with an initial commercial focus on Latin America and Southeast Asia. MIAMI, FL / ACCESS Newswire / August 24, 2026 / Regenerative Medical …